Cardiovascular Pharmacotherapy can Reduce Mortality

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.26, Iss.1, 2012-02, pp. : 85-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortality

By Pfützner Andreas Forst Thomas

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 463-476

Informa Healthcare

Access to resources Recommend Favorite

Valsartan can reduce the combined mortality and morbidity risk in patients with heart failure

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Cardiovascular Pharmacotherapy 2010: Foreword

By Cohn Jay

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 297-297

Springer Publishing Company

Access to resources Recommend Favorite

Interventional Cardiovascular Pharmacotherapy: Current Issues

By Abdallah G. Rebeiz Joseph Adams Robert A. Harrington

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 2, 2005-01 ,pp. : 93-102

Adis International

Access to resources Recommend Favorite

Cardiovascular Pharmacotherapy in Patients with Marfan Syndrome

By Yetman Anji T.

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 2, 2007-01 ,pp. : 117-126

Adis International

Access to resources Recommend Favorite